CG Oncology (CGON) Accounts Payables (2023 - 2026)

CG Oncology (CGON) has 4 years of Accounts Payables data on file, last reported at $8.2 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables rose 22.36% year-over-year to $8.2 million; the trailing twelve-month figure through Mar 2026 stood at $8.2 million (up 22.36% YoY), and the FY2025 full-year result was $5.7 million, down 12.32% from the prior year.
• Accounts Payables for Q1 2026 stood at $8.2 million, up from $5.7 million in the prior quarter.
• Across five years, Accounts Payables topped out at $11.3 million in Q3 2024 and bottomed at $3.2 million in Q4 2023.
• The 4-year median for Accounts Payables is $6.9 million (2024), against an average of $7.0 million.
• The widest annual swing landed in 2024, when Accounts Payables jumped 101.02%; it then slipped 18.85% in 2025.
• A 4-year view of Accounts Payables shows it stood at $3.2 million in 2023, then surged by 101.02% to $6.5 million in 2024, then retreated by 12.32% to $5.7 million in 2025, then surged by 44.14% to $8.2 million in 2026.
• The last three Accounts Payables figures came in at $8.2 million (Q1 2026), $5.7 million (Q4 2025), and $9.2 million (Q3 2025), per Business Quant data.

Peer Comparison